The University of Chicago Header Logo
Last Name


Search Results to Ravi Salgia

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Salgia, Ravi

Item TypeName
Concept Antibodies, Neoplasm
Concept Antibodies, Anti-Idiotypic
Concept Antibodies, Monoclonal
Concept Protein Engineering
Concept Antibodies, Monoclonal, Humanized
Concept Antibodies, Monoclonal, Murine-Derived
Concept Antibodies, Neutralizing
Concept Antibodies
Academic Article The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Academic Article The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Academic Article Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Academic Article Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
Academic Article Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
Academic Article Therapeutic targeting of receptor tyrosine kinases in lung cancer.
Academic Article Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trial.
Academic Article CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin.
Academic Article Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Academic Article Role of MetMAb (OA-5D5) in c-MET active lung malignancies.
Academic Article Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.
Academic Article EphB4 as a therapeutic target in mesothelioma.
Academic Article Teaching Video NeuroImages: myokymia and nerve hyperexcitability as components of Morvan syndrome due to malignant thymoma.
Academic Article Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
Academic Article Phase I dose-escalation study of onartuzumab as a single agent and in combination with bevacizumab in patients with advanced solid malignancies.
Academic Article A new hope for precision medicine.
Academic Article AXL mediates resistance to cetuximab therapy.
Academic Article Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Academic Article Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Academic Article Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of Paxillin.
Academic Article Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Academic Article Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.
Academic Article Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
Academic Article Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.
Academic Article Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors.
Academic Article Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report.
Academic Article Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
Academic Article RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells.
Academic Article Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.
Academic Article Near-Complete Response to Combined Pembrolizumab and Platinum-Doublet in a Patient With STK11/KRAS Mutated Advanced Lung Adenocarcinoma.
Academic Article Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC).

Search Criteria
  • Antibody
  • Engineering